Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Robert Powell

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Pharmacotherapy|March 26, 2004
Clinical pharmacists save thousands of lives: big decrease in dose-related adverse effectsJ Robert Powell
The New England Journal of Medicine|July 20, 2016
Point-of-Care Warfarin Monitoring in the ROCKET AF TrialJ Robert Powell
JAMA|June 24, 2015
Dosing Recommendations for New Oral Anticoagulants--ReplyJ Robert Powell
JAMA|March 11, 2015
Are new oral anticoagulant dosing recommendations optimal for all patients?J Robert Powell
Clinical Pharmacology and Therapeutics|November 9, 2020
Regarding Combined Pediatric and Adult Trials Submitted to the US Food and Drug Administration 2012-2018Jack Cook, Dan Weiner, J Robert Powell
Clinical Pharmacology and Therapeutics|May 24, 2020
A Real-World Evidence Framework for Optimizing Dosing in All Patients With COVID-19Richard W Peck, Daniel Weiner, Jack Cook, et al.
Clinical Pharmacology and Therapeutics|May 27, 2020
Drug Dosing Recommendations for All Patients: A Roadmap for ChangeJ Robert Powell, Jack Cook, Yaning Wang, et al.
Clinical Pharmacology and Therapeutics|September 1, 2020
Response to "Personalized Dosing = Approved Wide Dose Ranges + Dose Titration"J Robert Powell, Jack Cook, Yaning Wang, et al.
Clinical Pharmacology and Therapeutics|April 7, 2023
Dabigatran Dosing Proposal for Adults With Atrial Fibrillation: Stress-Testing Renal Function Range in Real World PatientsJ Robert Powell, Farah Al Qaraghuli, Jill Fiedler-Kelly, et al.
Journal of Clinical Pharmacology|June 26, 2015
A proposal for scientific framework enabling specific population drug dosing recommendationsPravin R Jadhav, Jack Cook, Vikram Sinha, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Pharmacotherapy|March 26, 2004
Clinical pharmacists save thousands of lives: big decrease in dose-related adverse effectsJ Robert Powell
The New England Journal of Medicine|July 20, 2016
Point-of-Care Warfarin Monitoring in the ROCKET AF TrialJ Robert Powell
JAMA|June 24, 2015
Dosing Recommendations for New Oral Anticoagulants--ReplyJ Robert Powell
JAMA|March 11, 2015
Are new oral anticoagulant dosing recommendations optimal for all patients?J Robert Powell
Clinical Pharmacology and Therapeutics|November 9, 2020
Regarding Combined Pediatric and Adult Trials Submitted to the US Food and Drug Administration 2012-2018Jack Cook, Dan Weiner, J Robert Powell
Clinical Pharmacology and Therapeutics|May 24, 2020
A Real-World Evidence Framework for Optimizing Dosing in All Patients With COVID-19Richard W Peck, Daniel Weiner, Jack Cook, et al.
Clinical Pharmacology and Therapeutics|May 27, 2020
Drug Dosing Recommendations for All Patients: A Roadmap for ChangeJ Robert Powell, Jack Cook, Yaning Wang, et al.
Clinical Pharmacology and Therapeutics|September 1, 2020
Response to "Personalized Dosing = Approved Wide Dose Ranges + Dose Titration"J Robert Powell, Jack Cook, Yaning Wang, et al.
Clinical Pharmacology and Therapeutics|April 7, 2023
Dabigatran Dosing Proposal for Adults With Atrial Fibrillation: Stress-Testing Renal Function Range in Real World PatientsJ Robert Powell, Farah Al Qaraghuli, Jill Fiedler-Kelly, et al.
Journal of Clinical Pharmacology|June 26, 2015
A proposal for scientific framework enabling specific population drug dosing recommendationsPravin R Jadhav, Jack Cook, Vikram Sinha, et al.
Pageof 2